Dear Friends and Colleagues,
The TREAT-NMD Alliance is organising its 5th international conference focussing on translational medicine in inherited neuromuscular diseases to be held 27th–29th November 2017 in Freiburg, Germany.
The aim of this international conference is to share progress and lessons learned in the area of translational medicine in inherited neuromuscular diseases and plan for the delivery of future therapies to patients.
The conference will attract over 300 delegates including academics, patients and carers, patient advocacy organisations and clinical specialists. Industry professionals will have the platform to:
- Network with partners on key issues and challenges in neuromuscular disease
- Engage with panels of international experts who will inform, challenge and stimulate debate
- Acquire the latest updates on standards of care, outcome measures, patient registries and new developments including addressing trial site capacity
This conference will be a fantastic opportunity for patients, academics, clinicians, patient registry curators and industry representatives, indeed all TREAT-NMD stakeholders, to get together to network, learn and exchange ideas about translational research. In light of demand for our last conference we encourage you to register as soon as you can.
We are now taking registrations for the conference at our early bird rate which will remain in effect until the end of May.
Look forward to meeting you in Freiburg.
|Professor Kevin Flanigan
Chair of the TREAT-NMD Alliance
|Professor Jan Kirschner
Conference Organizer &
Executive Committee Member